John C Clohisy Selected Research

Warfarin (Coumadin)

1/2016	The Effectiveness of a Risk Stratification Protocol for Thromboembolism Prophylaxis After Hip and Knee Arthroplasty.
11/2007	Optimal initial dose adjustment of warfarin in orthopedic patients.
4/2007	Failure of the American College of Chest Physicians-1A protocol for lovenox in clinical outcomes for thromboembolic prophylaxis.
6/2006	Efficacy of combined modality prophylaxis including short-duration warfarin to prevent venous thromboembolism after total hip arthroplasty.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

John C Clohisy Research Topics

Disease

35	Pain (Aches) 01/2023 - 02/2005
26	Congenital Abnormalities (Deformity) 11/2023 - 01/2004
20	Osteoarthritis 01/2023 - 02/2005
16	Osteolysis 08/2023 - 03/2002
13	Femoracetabular Impingement 11/2022 - 01/2005
10	Hip Dislocation 08/2022 - 02/2010
6	Infections 12/2023 - 12/2004
6	Arthritis (Polyarthritis) 01/2020 - 11/2003
6	Developmental Dysplasia of the Hip 05/2019 - 09/2010
5	Venous Thromboembolism 01/2021 - 06/2006
4	Wounds and Injuries (Trauma) 01/2021 - 04/2007
4	Surgical Wound Infection 07/2019 - 02/2015
4	Venous Thrombosis (Deep-Vein Thrombosis) 09/2016 - 06/2006
4	Osteonecrosis (Kienbock's Disease) 12/2014 - 07/2010
3	Disease Progression 01/2023 - 05/2011
3	Legg-Calve-Perthes Disease (Perthes Disease) 01/2021 - 04/2017
3	Heterotopic Ossification (Ectopic Ossification) 07/2019 - 06/2011
3	Pulmonary Embolism 09/2016 - 08/2014
2	Stress Fractures (Stress Fracture) 01/2023 - 09/2016
2	Hemorrhage 01/2021 - 09/2012
2	Inflammation (Inflammations) 01/2020 - 01/2020
2	Thromboembolism 01/2016 - 12/2015
2	Hip Osteoarthritis (Coxarthrosis) 05/2015 - 05/2012
2	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 08/2013 - 08/2012
2	Femoral Neck Fractures 01/2012 - 07/2010
1	Neurologic Manifestations (Neurological Manifestations) 07/2023
1	Slipped Capital Femoral Epiphyses 11/2022
1	Salter-Harris Fractures 01/2022
1	Nausea 01/2021
1	Atrial Fibrillation 01/2021
1	Hypotension (Low Blood Pressure) 01/2021
1	Drug Hypersensitivity (Drug Allergy) 01/2021
1	Hypersensitivity (Allergy) 01/2021
1	Wound Infection (Wound Infections) 07/2019
1	Neoplasms (Cancer) 12/2018
1	Multiple Hereditary Exostoses (Hereditary Multiple Exostoses) 04/2017
1	Hypesthesia (Numbness) 09/2016
1	Obesity 09/2015
1	Paralysis (Palsy) 12/2014
1	Vascular System Injuries 12/2014
1	Cartilage Diseases (Cartilage Disease) 08/2013
1	Down Syndrome (Down's Syndrome) 04/2013

Drug/Important Bio-Agent (IBA)

7	Polyethylene (Polythene)IBA 12/2023 - 12/2010
5	CytokinesIBA 08/2013 - 03/2002
4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021 - 06/2011
4	Warfarin (Coumadin)FDA LinkGeneric 01/2016 - 06/2006
3	Collagen Type II (Type II Collagen)IBA 01/2020 - 08/2013
3	Matrix Metalloproteinases (MMPs)IBA 01/2020 - 08/2013
3	3,5-tetrahydroaldosterone sulfate (THAS)IBA 02/2015 - 08/2012
2	1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA 01/2021 - 01/2020
2	DisintegrinsIBA 01/2020 - 01/2020
2	aggrecanaseIBA 01/2020 - 01/2020
2	ThrombospondinsIBA 01/2020 - 01/2020
2	Metalloproteases (Metalloproteinases)IBA 01/2020 - 01/2020
2	Aggrecans (Aggrecan)IBA 01/2020 - 01/2020
2	Matrix Metalloproteinase 13IBA 01/2020 - 01/2020
2	Anti-Bacterial Agents (Antibiotics)IBA 07/2019 - 09/2007
2	Polymethyl Methacrylate (Sol)IBA 07/2006 - 03/2002
2	NF-kappa B (NF-kB)IBA 11/2003 - 03/2002
1	ElementsIBA 11/2022
1	ORALIT (ORS)IBA 01/2022
1	Hematoxylin (Haematoxylon)IBA 01/2022
1	Alcian BlueIBA 01/2022
1	Narcotics (Narcotic Analgesics)IBA 01/2021
1	apixabanIBA 01/2021
1	1- phenyl- 3- azabicyclo(3.1.0)hexane- 2,4- dioneIBA 11/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	InterleukinsIBA 01/2020
1	Interleukin-1beta (Interleukin 1 beta)IBA 01/2020
1	Dihydrotachysterol (AT 10)IBA 11/2018
1	Biomarkers (Surrogate Marker)IBA 05/2015
1	Interleukin-8 (Interleukin 8)IBA 08/2013
1	Messenger RNA (mRNA)IBA 08/2013
1	ChemokinesIBA 08/2013
1	tyramine-deoxysorbitolIBA 07/2012
1	Lysergic Acid Diethylamide (LSD)IBA 05/2012

Therapy/Procedure

41	Osteotomy 11/2023 - 01/2004
24	Hip Replacement Arthroplasty (Total Hip Replacement) 01/2023 - 06/2006
15	Arthroplasty 01/2021 - 07/2010
7	Replacement Arthroplasty 01/2021 - 01/2007
6	Knee Replacement Arthroplasty (Total Knee Replacement) 01/2021 - 09/2007
5	Activities of Daily Living (ADL) 01/2020 - 01/2014
3	Conservative Treatment 01/2022 - 09/2009
3	Therapeutics 01/2022 - 01/2007
3	Reoperation 11/2020 - 08/2013
3	Operative Surgical Procedures 08/2012 - 01/2007
3	Bone Transplantation (Bone Grafting) 02/2011 - 01/2009
2	Physical Therapy Modalities (Physical Therapy Technique) 01/2023 - 11/2020
2	Aftercare (After-Treatment) 11/2022 - 07/2013
2	Decompression 12/2014 - 01/2005
1	Nerve Expansion 07/2023
1	Contraindications 01/2021
1	Spinal Anesthesia 01/2021
1	Debridement 07/2019
1	Punctures 09/2016
1	General Anesthesia 02/2015
1	Anesthesia 02/2015
1	Length of Stay 02/2015
1	Conduction Anesthesia (Regional Anesthesia) 02/2015
1	Hip Prosthesis 06/2014